Abstract
Advances in genetic analysis technology through free fetal DNA (fetal cell-free DNA - cffDNA) and the development of bioinformatics tools have facilitated non-invasive prenatal diagnostic (or test - NIPD or NIPT) and enabling the determination of sex, paternity and diagnosis of various chromosomal before birth. In this context, the NIPDs have gain importance, representing a safe alternati…
